Literature DB >> 18723938

Risk and disease.

Peter H Schwartz1.   

Abstract

The way that diseases such as high blood pressure (hypertension), high cholesterol, and diabetes are defined is closely tied to ideas about modifiable risk. In particular, the threshold for diagnosing each of these conditions is set at the level where future risk of disease can be reduced by lowering the relevant parameter (of blood pressure, low-density lipoprotein, or blood glucose, respectively). In this article, I make the case that these criteria, and those for diagnosing and treating other "risk-based diseases," reflect an unfortunate trend towards reclassifying risk as disease. I closely examine stage 1 hypertension and high cholesterol and argue that many patients diagnosed with these "diseases" do not actually have a pathological condition. In addition, though, I argue that the fact that they are risk factors, rather than diseases, does not diminish the importance of treating them, since there is good evidence that such treatment can reduce morbidity and mortality. For both philosophical and ethical reasons, however, the conditions should not be labeled as pathological. The tendency to reclassify risk factors as diseases is an important trend to examine and critique.

Entities:  

Mesh:

Year:  2008        PMID: 18723938     DOI: 10.1353/pbm.0.0027

Source DB:  PubMed          Journal:  Perspect Biol Med        ISSN: 0031-5982            Impact factor:   1.416


  10 in total

1.  Medicalization and overdiagnosis: different but alike.

Authors:  Bjørn Hofmann
Journal:  Med Health Care Philos       Date:  2016-06

2.  Disclosure and rationality: comparative risk information and decision-making about prevention.

Authors:  Peter H Schwartz
Journal:  Theor Med Bioeth       Date:  2009

3.  Epidemiology and the bio-statistical theory of disease: a challenging perspective.

Authors:  Élodie Giroux
Journal:  Theor Med Bioeth       Date:  2015-06

4.  The overdiagnosis of what? On the relationship between the concepts of overdiagnosis, disease, and diagnosis.

Authors:  Bjørn Hofmann
Journal:  Med Health Care Philos       Date:  2017-12

5.  Defining disease in the context of overdiagnosis.

Authors:  Mary Jean Walker; Wendy Rogers
Journal:  Med Health Care Philos       Date:  2017-06

6.  How to Draw the Line Between Health and Disease? Start with Suffering.

Authors:  Bjørn Hofmann
Journal:  Health Care Anal       Date:  2021-04-29

7.  The polysemy of psychotropic drugs: continuity and overlap between neuroenhancement, treatment, prevention, pain relief, and pleasure-seeking in a clinical setting.

Authors:  Eisuke Sakakibara
Journal:  BMC Med Ethics       Date:  2020-07-06       Impact factor: 2.652

Review 8.  Broadening risk factor or disease definition as a driver for overdiagnosis: A narrative review.

Authors:  João Pedro Bandovas; Beatriz Leal; Catarina Reis-de-Carvalho; David Cordeiro Sousa; João Cruz Araújo; Pedro Peixoto; Susana Oliveira Henriques; António Vaz Carneiro
Journal:  J Intern Med       Date:  2022-04       Impact factor: 13.068

9.  Too Much, Too Mild, Too Early: Diagnosing the Excessive Expansion of Diagnoses.

Authors:  Bjørn Hofmann
Journal:  Int J Gen Med       Date:  2022-08-06

10.  A typology of clinical conditions.

Authors:  Steven Tresker
Journal:  Stud Hist Philos Biol Biomed Sci       Date:  2020-05-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.